The coordinated expressional changes in eNOS and its allosteric regulator cav-1 may be viewed as a compensatory mechanism to maintain the production of bioactive nitric oxide in the face of developing LV hypertrophy in the setting of arterial hypertension. The gene discussed is CAV1; the disease is Hypertension.